Probing the Interface of HIV and Inflammaging
- PMID: 33709322
- DOI: 10.1007/s11904-021-00547-0
Probing the Interface of HIV and Inflammaging
Abstract
Purpose of review: Systemic inflammation increases as a consequence of aging (inflammaging) and contributes to age-related morbidities. Inflammation in people living with HIV is elevated compared with the general population even after prolonged suppression of viremia with anti-retroviral therapy. Mechanisms that contribute to inflammation during aging and in treated HIV disease are potentially interactive, leading to an exaggerated inflammatory phenotype in people with HIV.
Recent findings: Recent studies highlight roles for anti-retroviral therapy, co-infections, immune system alterations, and microbiome perturbations as important contributors to HIV-associated inflammation. These factors likely contribute to increased risk of age-related morbidities in people living with HIV. Understanding mechanisms that exaggerate the inflammaging process in people with HIV may lead to improved intervention strategies, ultimately, extending both lifespan and healthspan.
Keywords: Aging; HIV disease; Inflammation.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- Antiretroviral Therapy Cohort C. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293–9. https://doi.org/10.1016/S0140-6736(08)61113-7 . - DOI
-
- Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PloS one. 2013;8(12):e81355. https://doi.org/10.1371/journal.pone.0081355 . - DOI - PubMed - PMC
-
- •• Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, et al. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016. JAMA Network Open. 2020;3(6):e207954. https://doi.org/10.1001/jamanetworkopen.2020.7954 This matched cohort study of 39000 HIV-infected patients provides evidence of healthspan deficit in PWH. - DOI - PubMed - PMC
-
- Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. New Engl J Med. 1990;322(3):166–72. https://doi.org/10.1056/NEJM199001183220305 . - DOI - PubMed
-
- Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1988). 1993;6(8):904–12.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
